Cormedix to acquire Melinta Therapeutics
CorMedix Inc. a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC, a private commercial-stage company providing innovative therapies for acute and life-threatening illnesses announced a definitive agreement for CorMedix to acquire Melinta.